Trials / Unknown
UnknownNCT04882592
Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- SpineX Inc. · Industry
- Sex
- All
- Age
- 2 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Assessing the effects of noninvasive spinal cord neuromodulation on improving function in individuals with cerebral palsy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SCiP | Noninvasive spinal cord neuromodulator |
Timeline
- Start date
- 2021-05-15
- Primary completion
- 2023-12-01
- Completion
- 2024-12-01
- First posted
- 2021-05-12
- Last updated
- 2023-04-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04882592. Inclusion in this directory is not an endorsement.